year 17, Issue 6 (November - December 2023)                   Iran J Med Microbiol 2023, 17(6): 654-662 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Teymouri S, Chegini Z, Naseripour M, Aghaei H, Darbandi A, Bostanghadiri N et al . Molecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients. Iran J Med Microbiol 2023; 17 (6) :654-662
1- Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2- Department of Microbiology, School of Medicine, Hamedan University of Medical Sciences, Tehran, Iran
3- Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran
4- Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
5- Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran ,
Abstract:   (476 Views)

Background and Aim: Conjunctival squamous cell carcinoma (CSCC) is the final stage of ocular surface squamous neoplasia (OSSN). The microbiome plays a critical role in eye disease and health. Changes in the eye microbiome may be involved in the development of OSSN.
Materials and Methods: The sampling for this case-control study involved rolling sterile rayon-tipped swabs on the conjunctival tissue of both patients and controls. The detection of bacterial communities, including Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus),  Staphylococcus haemolyticus (S. haemolyticus), Corynebacterium spp., and Acinetobacter spp. The study was conducted using the TaqMan quantitative real-time polymerase chain reaction (qPCR) method, which targets the 16S rDNA gene from bacteria in various samples.
Results: The results showed that the frequency of Corynebacterium spp. was the same in both the patient and control groups (77.88%). Further, it exhibited the highest copy number compared to other bacteria. In general, a significant difference was observed in the total amounts of P.aeruginosa, S. aureus, and S. haemolyticus among patients, with a P-value < 0.001, additionally, Acinetobacter spp. showed a significant difference with a P-value = 0.004. 88.9% of S. haemolyticus (P=0.002) and 83.3% of P. aeruginosa (P=0.033) were detected in the OSSN group, and no detection of these bacteria was observed in any of the control samples.
Conclusion: The study found a significant difference in some bacterial strains between patients with OSSN and those without OSSN. Understanding the function and composition of the ocular surface microbiome can provide insights into ocular surface diseases.

Full-Text [PDF 729 kb]   (140 Downloads) |   |   Full-Text (HTML)  (29 Views)  
Type of Study: Original Research Article | Subject: Medical Bacteriology
Received: 2023/08/16 | Accepted: 2023/11/28 | ePublished: 2024/01/29

1. Cicinelli MV, Marchese A, Bandello F, Modorati G. Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther. 2018;7(2):247-62. [DOI:10.1007/s40123-018-0140-z] [PMID] [PMCID]
2. Jabbar HA, Haider Z. Effectiveness of combined therapy:(Intralesional injections and topical interferon) in treatment of ocular surface squamous neoplasia (OSSN). Asian j Multidiscip Stud. 2020;8:8. [DOI:10.5281/ZENODO.4460320]
3. Gurnani B, Kaur K. Ocular surface squamous neoplasia. StatPearls [Internet]: StatPearls Publishing; 2023.
4. Kiire CA, Stewart RM, Srinivasan S, Heimann H, Kaye SB, Dhillon B. A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom. Eye. 2019;33(2):283-94. [DOI:10.1038/s41433-018-0217-x] [PMID] [PMCID]
5. Hollhumer R, Michelow P, Williams S. Ocular surface squamous neoplasia: population demographics, pathogenesis and risk factors. African Vis Eye Health. 2020;79(1):1-8. [DOI:10.4102/aveh.v79i1.553]
6. Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmology. 2014;121(5):994-1000. [DOI:10.1016/j.ophtha.2013.11.017] [PMID] [PMCID]
7. Zilliox MJ, Gange WS, Kuffel G, Mores CR, Joyce C, de Bustros P, Bouchard CS. Assessing the ocular surface microbiome in severe ocular surface diseases. Ocul Surf. 2020;18(4):706-12. [DOI:10.1016/j.jtos.2020.07.007] [PMID] [PMCID]
8. Alonso VR, Guarner F. Linking the gut microbiota to human health. Br J Nutr. 2013;109(S2):S21-S6. [DOI:10.1017/S0007114512005235] [PMID]
9. Rocha-de-Lossada C, Mazzotta C, Gabrielli F, Papa FT, Gómez-Huertas C, García-López C, et al. Ocular Surface Microbiota in Naïve Keratoconus: A Multicenter Validation Study. J Clin Med. 2023;12(19):6354. [DOI:10.3390/jcm12196354] [PMID] [PMCID]
10. Aragona P, Baudouin C, Del Castillo JMB, Messmer E, Barabino S, Merayo-Lloves J, et al. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Surv Ophthalmol. 2021;66(6):907-25. [DOI:10.1016/j.survophthal.2021.03.010] [PMID]
11. Ren Z, Liu Q, Li W, Wu X, Dong Y, Huang Y. Profiling of diagnostic information of and latent susceptibility to bacterial keratitis from the perspective of ocular bacterial microbiota. Front Cell Infect Microbiol. 2021;11:645907. [DOI:10.3389/fcimb.2021.645907] [PMID] [PMCID]
12. Miller D, Iovieno A. The role of microbial flora on the ocular surface. Curr Opin Allergy Clin Immunol. 2009;9(5):466-70. [DOI:10.1097/ACI.0b013e3283303e1b] [PMID]
13. Petrillo F, Pignataro D, Lavano MA, Santella B, Folliero V, Zannella C, et al. Current evidence on the ocular surface microbiota and related diseases. Microorganisms. 2020;8(7):1033. [DOI:10.3390/microorganisms8071033] [PMID] [PMCID]
14. Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities. Clin Microbiol Infect. 2016;22(7):643. e7-. e12. [DOI:10.1016/j.cmi.2016.04.008] [PMID]
15. Zhou Y, Holland MJ, Makalo P, Joof H, Mabey DC, Bailey RL, et al. The conjunctival microbiome in health and trachomatous disease: a case control study. Genome Med. 2014;6(11):1-10. [DOI:10.1186/s13073-014-0099-x] [PMID] [PMCID]
16. Ozkan J, Coroneo M, Willcox M, Wemheuer B, Thomas T. Identification and visualization of a distinct microbiome in ocular surface conjunctival tissue. Investig Ophthalmol Vis Sci. 2018;59(10):4268-76. [DOI:10.1167/iovs.18-24651] [PMID]
17. Shin H, Price K, Albert L, Dodick J, Park L, Dominguez-Bello MG. Changes in the eye microbiota associated with contact lens wearing. MBio. 2016;7(2):e00198. [DOI:10.1128/mBio.00198-16] [PMID] [PMCID]
18. Doan T, Akileswaran L, Andersen D, Johnson B, Ko N, Shrestha A, et al. Paucibacterial microbiome and resident DNA virome of the healthy conjunctiva. Investig Ophthalmol Vis Sci. 2016;57(13):5116-26. [DOI:10.1167/iovs.16-19803] [PMID] [PMCID]
19. Kugadas A, Gadjeva M. Impact of microbiome on ocular health. Ocul Surf. 2016;14(3):342-9. [DOI:10.1016/j.jtos.2016.04.004] [PMID] [PMCID]
20. O'Callaghan RJ. The pathogenesis of Staphylococcus aureus eye infections. Pathogens. 2018;7(1):9. [DOI:10.3390/pathogens7010009] [PMID] [PMCID]
21. Campolo A, Pifer R, Shannon P, Crary M. Microbial Adherence to Contact Lenses and Pseudomonas aeruginosa as a Model Organism for Microbial Keratitis. Pathogens. 2022;11(11):1383. [DOI:10.3390/pathogens11111383] [PMID] [PMCID]
22. Wang Y, Ding Y, Jiang X, Yang J, Li X. Bacteria and dry eye: A narrative review. J Clin Med. 2022;11(14):4019. [DOI:10.3390/jcm11144019] [PMID] [PMCID]
23. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369-79. [DOI:10.1056/NEJMra1600266] [PMID]
24. Navab-Moghadam F, Sedighi M, Khamseh ME, Alaei-Shahmiri F, Talebi M, Razavi S, Amirmozafari N. The association of type II diabetes with gut microbiota composition. Microb Pathog. 2017;110:630-6. [DOI:10.1016/j.micpath.2017.07.034] [PMID]
25. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012;41(D1):D590-D6. [DOI:10.1093/nar/gks1219] [PMID] [PMCID]
26. Dannemiller KC, Gent JF, Leaderer BP, Peccia J. Influence of housing characteristics on bacterial and fungal communities in homes of asthmatic children. Indoor Air. 2016;26(2):179-92. [DOI:10.1111/ina.12205] [PMID] [PMCID]
27. Lee AY, Akileswaran L, Tibbetts MD, Garg SJ, Van Gelder RN. Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencing. Ophthalmology. 2015;122(3):524-30. [DOI:10.1016/j.ophtha.2014.09.001] [PMID] [PMCID]
28. Vishwakarma P, Mitra S, Beuria T, Barik MR, Sahu SK. Comparative profile of ocular surface microbiome in vernal keratoconjunctivitis patients and healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2021;259(7):1925-33. [DOI:10.1007/s00417-021-05109-z] [PMID]
29. Graham JE, Moore JE, Jiru X, Moore JE, Goodall EA, Dooley JS, et al. Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Investig Ophthalmol Vis Sci. 2007;48(12):5616-23. [DOI:10.1167/iovs.07-0588] [PMID]
30. Al-Hakami AM, Al-Amri A, Abdulrahim I, Hamid ME. Is there is an association between the presence of Staphylococcus species and occurrence of vernal keratoconjunctivitis? Saudi J Ophthalmol. 2015;29(4):255-8. [DOI:10.1016/j.sjopt.2015.05.002] [PMID] [PMCID]
31. Lee SH, Oh DH, Jung JY, Kim JC, Jeon CO. Comparative ocular microbial communities in humans with and without blepharitis. Investig Ophthalmol Vis Sci. 2012;53(9):5585-93. [DOI:10.1167/iovs.12-9922] [PMID]
32. Kugadas A, Wright Q, Geddes-McAlister J, Gadjeva M. Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA. Investig Ophthalmol Vis Sci. 2017;58(11):4593-600. [DOI:10.1167/iovs.17-22119] [PMID] [PMCID]
33. Venugopal R, Satpathy G, Sangwan S, Kapil A, Aron N, Agarwal T, et al. Conjunctival microbial flora in ocular Stevens-Johnson syndrome sequelae patients at a tertiary eye care center. Cornea. 2016;35(8):1117-21. [DOI:10.1097/ICO.0000000000000857] [PMID]
34. Zaidi T, Zaidi T, Yoong P, Pier GB. Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Investig Ophthalmol Vis Sci. 2013;54(7):4430-8. [DOI:10.1167/iovs.13-11701] [PMID] [PMCID]
35. Leger AJS, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, et al. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal γδ T cells. Immunity. 2017;47(1):148-58. e5. [DOI:10.1016/j.immuni.2017.06.014] [PMID] [PMCID]
36. Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121-6. [DOI:10.4103/aam.aam_56_18] [PMID] [PMCID]
37. Kay J, Thadhani E, Samson L, Engelward B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair. 2019;83:102673. [DOI:10.1016/j.dnarep.2019.102673] [PMID] [PMCID]
38. Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in A frica. Trop Med Int Health. 2013;18(12):1424-43. [DOI:10.1111/tmi.12203] [PMID] [PMCID]
39. Chauhan S, Sen S, Sharma A, Tandon R, Kashyap S, Pushker N, et al. American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India. Arch Pathol Lab Med. 2014;138(11):1488-94. [DOI:10.5858/arpa.2013-0353-OA] [PMID]
40. Ma I-H, Hu F-R, Wang I-J, Chen W-L, Hsu Y-J, Chu H-S, et al. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014. J Formos Med Assoc. 2019;118(4):776-82. [DOI:10.1016/j.jfma.2018.09.001] [PMID]
41. Sedighi M, Razavi S, Navab-Moghadam F, Khamseh ME, Alaei-Shahmiri F, Mehrtash A, Amirmozafari N. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 2017;111:362-9. [DOI:10.1016/j.micpath.2017.08.038] [PMID]
42. Hussain I, Khan BS. Ocular surface squamous neoplasia: clinicopathological analysis and treatment outcome of 65 cases. J Coll Physicians Surg Pak. 2020;30(9):970-3. [DOI:10.29271/jcpsp.2020.09.970] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc